Paper66471
Treatment of symptomatic diverticular disease with a high-fibre diet.
Brodribb AJ. Lancet, 1977. Cited by 163 papers, by iCite.
Cite this record
ConductScience Library. Treatment of symptomatic diverticular disease with a high-fibre diet. Papers, record 66471. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/66471
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cellulose | Major topic |
| Dietary Fiber | Major topic |
| Diverticulitis, Colonic | Major topic |
| Aged | |
| Clinical Trials as Topic | |
| Evaluation Studies as Topic | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Time Factors | |
| Triticum |
Source PubMed
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 163 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40005051 | Positive Effect of Lecithin-Based Delivery Form of Curcuma and Boswellia Extracts on Irritable Bowel Syndrome After COVID-19 Infection. | Nutrients | 2025 | https://conductscience.org/library/papers/40005051 | PubMed |
| 39598208 | Positive Outcomes of Supplementation with Lecithin-Based Delivery Formulation of Curcuma longa and Boswellia serrata in IBS Subjects with Small Bowel Dysbiosis. | Life (Basel) | 2024 | https://conductscience.org/library/papers/39598208 | PubMed |
| 35565826 | Positive Effects of a Lecithin-Based Delivery Form of Boswellia serrata Extract in Acute Diarrhea of Adult Subjects. | Nutrients | 2022 | https://conductscience.org/library/papers/35565826 | PubMed |
| 35276778 | Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulation of Curcuma longa and Boswellia serrata Extracts in Subjects with Irritable Bowel Syndrome and Small Bowel Dysbiosis. | Nutrients | 2022 | https://conductscience.org/library/papers/35276778 | PubMed |
| 33408751 | Symptomatic uncomplicated diverticular disease management: an innovative food-grade formulation of Curcuma longa and Boswellia serrata extracts. | Drugs Context | 2020 | https://conductscience.org/library/papers/33408751 | PubMed |
| 33208922 | Dietary fibre in gastrointestinal health and disease. | Nat Rev Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33208922 | PubMed |
| 30084005 | High intake of dietary fibre from fruit and vegetables reduces the risk of hospitalisation for diverticular disease. | Eur J Nutr | 2019 | https://conductscience.org/library/papers/30084005 | PubMed |
| 28230737 | Role of Fiber in Symptomatic Uncomplicated Diverticular Disease: A Systematic Review. | Nutrients | 2017 | https://conductscience.org/library/papers/28230737 | PubMed |
| 26989377 | Risk Factors for Diverticulosis, Diverticulitis, Diverticular Perforation, and Bleeding: A Plea for More Subtle History Taking. | Viszeralmedizin | 2015 | https://conductscience.org/library/papers/26989377 | PubMed |
| 26752946 | Recent advances in the treatment of colonic diverticular disease and prevention of acute diverticulitis. | Ann Gastroenterol | 2016 | https://conductscience.org/library/papers/26752946 | PubMed |
| 26458921 | Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon. | Dig Dis Sci | 2016 | https://conductscience.org/library/papers/26458921 | PubMed |
| 25360320 | Italian consensus conference for colonic diverticulosis and diverticular disease. | United European Gastroenterol J | 2014 | https://conductscience.org/library/papers/25360320 | PubMed |
| 24343275 | Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis--a prospective randomized study. | Int J Colorectal Dis | 2014 | https://conductscience.org/library/papers/24343275 | PubMed |
| 24179670 | Preventing recurrent acute diverticulitis with pharmacological therapies. | Ther Adv Chronic Dis | 2013 | https://conductscience.org/library/papers/24179670 | PubMed |
| 23634185 | New strategies for the management of diverticular disease: insights for the clinician. | Ther Adv Gastroenterol | 2013 | https://conductscience.org/library/papers/23634185 | PubMed |
| 21922199 | A systematic review of high-fibre dietary therapy in diverticular disease. | Int J Colorectal Dis | 2012 | https://conductscience.org/library/papers/21922199 | PubMed |
| 21876861 | Diverticular disease: epidemiology and management. | Can J Gastroenterol | 2011 | https://conductscience.org/library/papers/21876861 | PubMed |
| 21577292 | Diverticular disease: A therapeutic overview. | World J Gastrointest Pharmacol Ther | 2010 | https://conductscience.org/library/papers/21577292 | PubMed |
| 21279478 | Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease. | Intern Emerg Med | 2012 | https://conductscience.org/library/papers/21279478 | PubMed |
| 20676258 | The medical and nonoperative treatment of diverticulitis. | Clin Colon Rectal Surg | 2009 | https://conductscience.org/library/papers/20676258 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/66471
GET https://conductscience.org/api/papers/v1/66471/cited_by?page=2